← Back to Briefing
US Reclassifies State-Licensed Marijuana to Lower-Risk Drug Category
Importance: 65/1001 Sources
Why It Matters
This marks a historic shift in federal drug policy, reflecting evolving scientific understanding and state-level legalization trends. It could open doors for more research, alleviate tax burdens on cannabis businesses, and potentially pave the way for broader federal reform.
Key Intelligence
- ■The U.S. government has officially proposed reclassifying marijuana from Schedule I to Schedule III under the Controlled Substances Act.
- ■This move acknowledges that state-licensed marijuana has accepted medical uses and a lower potential for abuse than previously recognized.
- ■The decision follows a recommendation from the Department of Health and Human Services (HHS) based on scientific review.
- ■Reclassification to Schedule III would significantly ease federal restrictions on cannabis, potentially impacting research, taxation, and the legal cannabis industry.